贵阳粥样下肢动脉硬化挂什么科(贵阳红胎记什么医院看的好) (今日更新中)

SAN FRANCISCO, May 11 (Xinhua) -- Google on Wednesday introduced a series of notebook computers based on its Chrome operating system, stepping up its competition against Microsoft.Google unveiled the "Chromebook" at its annual developers conference in San Francisco, saying that the new devices, made by Acer and Samsung Electronics, will go on sale on June 15 in the United States and six European countries.Google said Chromebooks can boot in 8 seconds and its security system makes it require no virus protection. Applications, documents and setting will be stored in "the cloud," which enables users to have same experience after logging into another Chromebook. The system will get updated automatically with no update prompts.Acer's Chromebook will start at 349 U.S. dollars and Samsung's product will be priced at 429 dollars for its WiFi model and 499 dollars for 3G connectivity. The devices will be available online in the United States through Amazon.com and Best Buy's online store.Google on Wednesday also announced Chromebooks for Business and Education, a subscription service including Chromebooks and a cloud management console to remotely administer and manage users, devices applications and policies.Google said it will directly handle the business and education orders. The monthly fee will be 28 dollars per user for businesses and 20 dollars per user for educational customers.The Chrome operating system, announced in July 2009, is designed to work exclusively with web applications, with its work based on Google's Chrome web browser.On Wednesday's conference, Google said the Chrome web browser now has 160 million active users, compared to 70 million last May.

BEIJING, March 5 (Xinhua) -- China's retailers will offer refund to recent buyers of iPad 1 as price dropped with the debut of iPad 2.Apple released the upgraded version of the tablet on March 3 and announced to lower the price tags of the first generation iPad 1 by up to 27.6 percent. Buyers of iPad 1 within the last two weeks are eligible for a price difference compensation, according to Apple.Chinese customers who bought the product via Apple China online or its chain stores will also be compensated, according to a statement on Apple's website.Chinese electronics retailers such as Suning and Gome responded quickly to the price cut, promising to pay back their customers with a refund.Suning, China's biggest electronics retailer by market value, said iPad 1 buyers who bought the product from Feb 17 to March 2 can get the refund with the receipt starting Saturday.Gome, the second largest electronics retailer in China, also announced to pay back their customers who bought the product from Feb 18 to March 3 from their stores. Customers could apply for the refund with the receipt starting Sunday.

NANJING, April 23 (Xinhua) -- At a time when almost every commodity in China is getting more expensive, the dwindling cost of medicine is a rarity.Zhang Jinkui, a hypertension patient, buys medicines from the community health center of his neighborhood in Changzhou, a city in east China's coastal Jiangsu Province.His prescription list includes Aspirin Enteric-coated tablets, down to 1.4 yuan from 4.7 yuan (0.7 U.S. dollars) per unit, and Fosinopril Sodium Tablets, down to 41.39 yuan from 51.6 yuan per unit.Both drugs are found on the essential drug list unveiled in 2009. The list names the 307 most common western and traditional Chinese medicines, which are heavily subsidized so hospitals can sell them at cost price.A consumer buys medicines with the help of a retailer at a pharmacy in Lianyungang, east China's Jiangsu Province, March 28, 2011.All essential medicines are listed by their generic names, and drug producers compete to supply essential medicines through public procurement.Due to a long history of low government funding for state-run hospitals, which often covers only 10 percent of the hospitals' operating costs, doctors have generated income for hospitals by aggressively prescribing expensive, and sometimes unnecessary, medicines and treatments.The essential medicine system and the reform of publicly funded hospitals, two pillars of China's health reform, are designed to address high medical costs and low accessibility of medical services.In April 2009, China kicked off health reforms aimed at correcting these long-standing problems facing China's health system and easing public grievances.Two years later, the essential medicine system has reduced drug prices, but still fails to please hospitals, patients and drug producers.The system requires government-funded grassroots health clinics, including urban community health centers and rural clinics, to prescribe only essential medicines and to sell these medicines at cost price, rather than with the previous 15 percent mark-up.Such policies have brought hard times to grassroots health clinics, especially in cash-strapped areas.Song Wenzhi, a public health professor at Peking University, said "Grassroots health clinics, without the expertise to perform operations and other treatments, rely heavily on selling drug," adding that these hospitals have found themselves scraping by due to the zero percent mark-up policy.Wang Zhiying, Vice Director of the People's Hospital of Anxiang County in the city of Changde, Hunan Province, said four grassroots hospitals in Changde tested the essential medicine system as pilot projects, but the zero percent mark-up policy took away 60 to 70 percent of the hospitals' revenue.Wang was quoted by "Health News," a newspaper run by China's Ministry of Health, as saying that, due to financial difficulties, the county government had not yet channeled the 8 million yuan (1.2 million U.S.dollars) in support funds into the hospitals' accounts, resulting in the resignations of many doctors.The essential medicine system covers 60 percent of government-funded grassroots hospitals and drug prices have fallen by an average of 30 percent, said Sun Zhigang, Director of the Health Reform Office under the State Council, or China's Cabinet.According to the health reform plan for 2011, the essential medicine system will cover all government-sponsored health institutions at the grassroots level by the end of the year and drugs will be sold there at a zero percent mark-up.Song Wenzhi said the key will be the commitment of local governments to health reform and their financial input. This way, essential medicines can benefit the public without bankrupting grassroots health institutions."That would be a great sum of money." said Song, citing his own studies. "There are roughly 5,000 government-funded hospitals in China. One third of them make profits, one third barely break even, and still one third rely heavily on government subsidies."To maintain the poorest hospitals, central and local level governments would need to invest 15 billion yuan (2.3 billion U.S. dollars) each year, according to Song's estimate.

BEIJING, Feb. 1 (Xinhua) -- Wu Bangguo, chairman of the Standing Committee of the National People's Congress of China, on Monday sent congratulatory messages to Myanmar's newly-elected upper house speaker U Khin Aung Myint and lower house speaker Thura U Shwe Mann, respectively,on their taking offices.Myanmar's house of nationalities (upper house) session on Monday elected U Khin Aung Myint, Minister of Culture, as speaker of the upper house.Also on Monday, No. 3 Myanmar state leader Thura U Shwe Mann, who is a member of the State Peace and Development Council and previously the Chief of General Staff of the army, the navy and the air force, was elected as speaker of the house of representatives by the house of representatives (lower house).

BEIJING, March 21 (Xinhua) -- Renowned Chinese liquor producer Kweichow Moutai Co., Ltd. announced Monday its annual net profit in 2010 rose 17.13 percent year on year on strong market demand.Its net profit hit 5.05 billion yuan (769.17 million U.S. dollars), the Guizhou-based firm said in its 2010 annual report filed to Shanghai Stock Exchange.The company's annual business revenue increased 20.3 percent from one year earlier to 11.63 billion yuan while earnings per share stood at 5.35 yuan.The economic rebound accelerated the development of liquor industry despite rising raw material prices, said the report.The A-share price of the upmarket distiller opened down 0.70 percent from the previous close to 189.8 yuan Monday.

来源：资阳报